Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome

Class:Id	LiteratureReference:2012014
_displayName	Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome
_timestamp	2011-11-22 14:55:28
author	[Person:2011812] Yu, K [Person:2011600] Herr, AB [Person:184486] Waksman, G [Person:190249] Ornitz, DM
created	[InstanceEdit:2012015] Rothfels, K, 2011-11-22
journal	Proc Natl Acad Sci U S A
pages	14536-41
pubMedIdentifier	11121055
title	Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome
volume	97
year	2000
(literatureReference)	[DefinedSet:2065925] FGFR2b mutant-binding FGFs [extracellular region] [Homo sapiens] [Reaction:2012074] FGFR3c P250R mutant binds to ligand with enhanced affinity [Homo sapiens] [Reaction:2023451] FGFR1c P252X mutants bind ligand with enhanced affinity [Homo sapiens] [Reaction:2033472] FGFR2c mutants bind an expanded range of ligands [Homo sapiens] [Reaction:2033474] FGFR2b mutants bind an expanded range of ligands [Homo sapiens] [Pathway:2033519] Activated point mutants of FGFR2 [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome (2012014)